Chennai-based Take Solutions Ltd has reported a 50 per cent increase in net profit to ₹24 crore for the third quarter ended December 31, 2015 against ₹16 crore for the corresponding period last year. Revenue increased by 30 per cent to ₹248 crore (₹185 crore) as its clients in North America continued to spend on life sciences and supply chain solutions. During the quarter, the company acquired Ecron Acunova, a life sciences services player, to explore emerging vistas of Biosimilars, Regenerative Medicine and Diagnostic Imaging Agents, for ₹115 crore. It also launched PVIndia, a pharma covigilance peer network to provide a forum for the pharmaceutical industry to discuss and ideate on solutions for challenges faced, says a company press release.

HR Srinivasan, Vice-Chairman and MD, in the press release said the results reflect the success of its strategy to emerge as a 360 degree player in the domain life sciences. Our Bureau

On the Bombay Stock Exchange, the company’s share priced closed at ₹145.85, down by ₹9.50.

comment COMMENT NOW